Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 25;16(3):e0248074. doi: 10.1371/journal.pone.0248074

Asymptomatic Plasmodium infection and associated factors among pregnant women in the Merti district, Oromia, Ethiopia

Bereket Wake Subussa 1, Teferi Eshetu 2, Teshome Degefa 2, Musa Mohammed Ali 3,*
Editor: Sammy O Sam-Wobo4
PMCID: PMC7993780  PMID: 33765017

Abstract

Background

Asymptomatic Plasmodium infection (API) that occurs during pregnancy increases the risk of stillbirths, abortion, premature delivery, and low birth weight. API also hinders the control and prevention of malaria as infected hosts serve as silent reservoirs for transmission of Plasmodium species in the community.

Objective

The aim of this study was to determine the prevalence of API and associated factors among pregnant women. This community-based cross-sectional study was conducted at Merti district, Oromia, Ethiopia among 364 pregnant women from March to September 2018.

Methods

Sociodemographic and obstetrics features were collected using a structured questionnaire. About 2ml of blood was collected from participants to detect Plasmodium species, gametocyte carriage rate, parasite density, and anemia.

Results

The prevalence of API among pregnant women was 3.6%. The proportion of Plasmodium falciparum and Plasmodium vivax was 6(46.2%) and 7(53.8%) respectively. Out of 13 Plasmodium species identified, Gametocyte carriage rate was 4(30.7%). The geometric mean density of the asexual stage of the parasites was 994.7(interquartile [IQR], 320 to 2200) parasites/ul. The geometric mean gametocyte density was 303.3 (interquartile range [IQR], 160 to 600). The proportion of anemia among Plasmodium-infected participants was 12(92.3%). Previous infection by Plasmodium species (AOR = 5.42; 95% CI: 1.19–29.03, p = 0.047), lack of insecticide-treated bed net use (AOR = 6.52; 95% CI: 1.17–36.44, p = 0.032), and living close to stagnant water (AOR = 4.18; 95% CI (1.12–17.36, p = 0.049) were significantly associated with API. Anemia was significantly higher among Plasmodium-infected than non-infected pregnant women (x2 = 27.62, p <0.001).

Conclusion

In the current study, a relatively high prevalence of API was detected among pregnant women. Identifying API in the community is important to prevent the unwanted outcomes of Plasmodium infection and its transmission.

Introduction

Malaria is an infectious disease caused by a protozoan parasite of the genus Plasmodium. Plasmodium falciparum is the most prevalent and causes most of the fatal infections in Africa [1]. Infection occurring outside of Africa is mostly due to Plasmodium vivax, as it is capable to develop in a wider range of temperatures [1]. According to the World Health Organization (WHO) report of 2018, P. falciparum is the most prevalent in the African, South-East Asia, Eastern Mediterranean, and the Western Pacific Regions. However, P. vivax is the predominant parasite in the WHO Region of the Americas, representing 75% of malaria cases [2]. There are also growing pieces of evidence that show the high transmission of P. vivax in Africa [3].

Approximately, 228 million malaria cases and 405000 deaths occurred worldwide in 2018; most of the malaria-related cases and deaths were from Africa. Between 2015 and 2018, among malaria-endemic countries, only 31 of them were on the way to reduce the incidence by about 40% or more by the year 2020 [2]. More than 10 million pregnant women in moderate and high Plasmodium transmission countries were exposed to plasmodium infection in 2018. Out of 11 million pregnant women exposed to Plasmodium infections in the year 2019 give birth to about 872000 babies with low birth-weight [2]. About 30−40 Anopheles species are responsible for the transmission of malaria. Among them, Anopheles arabiensis is the primary vector of malaria in Ethiopia [4, 5].

Malaria during pregnancy affects the mother, fetus, and neonates [6]. It increases the risk of stillbirths, spontaneous abortion, premature delivery, and low birth weight [7]. In the African continent, where the greatest burden of malaria occurs, about 30 million women living in malaria-endemic regions become expectant each year. Malaria is a threat to these women and their babies, with up to 200,000 newborn deaths occurring each year as a result of malaria in pregnancy [7]. Although patients with subclinical infections do not present with malaria symptoms, they contribute to the cycle of transmission in a population. The relative contribution of sub-clinical infection has considerable implications for the design and use of elimination diagnostics [8].

In malaria-endemic areas, a significant proportion of individuals have an asymptomatic infection with Plasmodium species among which pregnant women are at higher risk [9]. In asymptomatic parasitemia, the person carries Plasmodium parasites in their bloodstream, but due to partial immunity, the parasites are incapable of inducing symptoms to the affected individual. Nevertheless, the infected person could transfer the parasites to other individuals via mosquito bite [10].

In areas where the transmission of malaria is seasonal, during the dry season Plasmodium species survive in the bloodstream of the asymptomatic persons. This allows malaria to resume to the population during the wet season [11]. During the following pregnancies, however, anti-VAR2CSA (Variant 2 chondroitin sulfate A) antibodies can be found in pregnant women’s circulation, giving them protective immunity against these variant parasites [11].

Asymptomatic malaria can be observed in both stable endemic areas and unstable transmission areas [12, 13]. However, much attention has been given to symptomatic Plasmodium infections, relatively little attention has been paid to asymptomatic malaria. Although it is difficult to define asymptomatic malaria because of the lack of standard diagnostic criteria, the most widely used criteria include the presence of parasites in peripheral thick blood smears, an axillary temperature below 37.5°C, and the absence of malaria-related symptoms [14].

In Ethiopia, there are different data on the prevalence of asymptomatic malaria and risk factors at the institutional level, but there is scarce data on asymptomatic malaria among pregnant women at the community level in general and particularly in the current study area. National Malaria Control and Elimination Programs are geared towards the protection of pregnant women living in malaria-endemic zones because of their reduced immunity [15]. Therefore, the present study was designed to determine the prevalence of asymptomatic Plasmodium infection (API) and associated factors during pregnancy.

Materials and methods

Study design and area

A community-based cross-sectional study was conducted to determine the prevalence and predictors of API among pregnant women in Merti district, Oromia, Ethiopia from March to September 2018. Merti district is located in Southeastern Oromia; it lies in a tropical climatic zone with an altitude of 1,000–3,280 meters above sea level, an average annual temperature of 26°C and rainfall of 600mm. The District consists of 22 villages, of which 17 have been known as malarious villages with an intense transmission pattern. The total population of Merti district was116, 822, of whom 60,257 were men and 56,565 were women; 22,539 of its population were urban dwellers [16].

Study population

All pregnant women living in the selected Village of Merti district during the study period and fulfill the inclusion criteria.

Inclusion and exclusion criteria

Pregnant women without signs and symptoms of malaria (fever, chills, rigor, nausea, vomiting, headache, joint/muscle pains, and anorexia) within the last 48 hours, axillary temperature ≤ 37°c, permanent residents in the study area and those willing to participate in the study, and signed the informed consent were included. Pregnant women who had taken antimalarial drugs in the last two weeks before the study period were excluded from the study.

Sample size determination

The sample size was determined using a single population proportion formula using the following assumptions: previous prevalence of asymptomatic malaria among pregnant women reported from Arba Minch, Ethiopia (9.4%) [17]; 95% confidence interval, 3% margin of error, 10% non-response. The calculated sample size was 400. Merti woreda has 22 kebeles, of which 11 kebeles were randomly selected for this study by using a simple random sampling method. Since the total number of asymptomatic pregnant women found in selected kebeles during the study period was less than the calculated sample size, all (N = 364) asymptomatic pregnant women were included in the study. The distribution of pregnant women based on where they belong (kebele) is as follows: Worsha kona (n = 11), Woticha dole (n = 18), Abomsa 01 (n = 37) Ashe (n = 13), Wataro (n = 45), Shemo (n = 12), Hella-kiyya (n = 22), Abomsa 02 (n = 28), Gologota (n = 96) Dembeka-iftu (n = 52), Dembeka-gadjele (n = 30).

Variables of the study

Dependent variables

Prevalence of API among pregnant women.

Independent variables

Age, Residence, Gestational age, Previous infection with Plasmodium, Living close to stagnant water, Indoor residual spray, use of insecticide-treated bed net, Gravida, ANC attendance, Anemia.

Data collection

A structured questionnaire was used to collect sociodemographic and obstetric data. Information collected includes age, number of children, educational status, knowledge of malaria prevention, ownership of ITN, sleeping under the ITN, and use of the IRS.

About 2ml of the blood sample was collected from study participants from a peripheral vein into an Ethamine Diamine Tetra acetic Acid (EDTA) tube for preparation of thick and thin blood film. Rapid diagnostic test (RDT) and microscopy were used for the detection of Plasmodium species. Thick and thin blood smears were made on the same slide, fixed by methanol, air-dried, and transported to Abomsa and Gologota Health centers. The slides were stained with 10% Giemsa for 15 minutes and screened for the presence of Plasmodium species by using a microscope. RDT was performed according to the manufacturer’s manual.

Asexual parasite density per microliter (μl) of blood was determined by counting the number of parasites per 200 white blood cells on a thick blood film assuming a total standard white blood cell (WBC) count of 8000/μl [18]. The degree of parasite density was graded as mild, moderate, and severe when the counts were between 1–999 parasites/μl, 1000–9999/μl, and >10,000/μl respectively, following the method described elsewhere [19].

Gametocyte density was quantified against 500 leukocytes in the thick blood films. This was converted to the number of gametocytes per microliter of blood, assuming a standard approximation of leukocyte count of 8,000/ μl. A smear was considered negative if no parasites were seen after viewing 100 high-powered fields.

To determine anemia, two packed cell volume was used. Briefly, two heparinized capillary tubes of a 4-5cm column were filled with blood, one end of the capillary tube was sealed with plasticin, and samples were assembled in the Centrifuge (hematocrit machine) and spun at 5000 revolutions per minute for 5 minutes. The Packed cell volume (PCV) was read using Hawksleys microhematocrit reader. A study participant was considered anemic if the value of PCV was below 33%, according to WHO recommendation [20, 21].

Data processing and analysis

Data were coded, entered into Epidata version 3.1, cleaned, and analyzed using SPSS version 20.0. Both descriptive and inferential statistics were used to analyze the data. The frequency was used to determine the prevalence of API among pregnant women. A bivariate and multivariable regression model was used to assess factors associated with asymptomatic malaria. A chi-square test was used to determine the association between malaria and anemia among pregnant women. Prevalence figures were calculated for the total study participants and the association between variables was calculated. A p-value of less than 0.05 was considered statistically significant.

Quality control

The training was provided for data collectors on the data collection procedure. Originally the questionnaire was prepared in English; translated into Afan Oromo and Amharic language and then translated back to English. Prior to testing on actual study participants, all version of the questionnaire (English, Afan Oromo, and Amharic) were checked for accuracy and consistency. The questionnaire was also pretested on 5% of the total sample size and it is provided as S1 File. As part of validating the questionnaire, it was reviewed by two different individuals, pilot test was conducted, collected data was analyzed, internal consistency was checked, and finally the questionnaire was revised.

All laboratory materials such as rapid test kits, slides, thermometers, EDTA tube, and sample transporting system were checked for the expiration date, correct collection procedures, and samples as well as inbuilt control appearances by experienced laboratory professionals. One slide was examined by two laboratory professionals. The manufacturer’s instruction was strictly followed for the RDTs. All data were double entered to reduce data entry errors.

Ethics approval and consent to participate

This study was ethically approved by Institutional Review Board of Institute of Health, Jimma University. Permission was obtained from the Arsi Zone Health Bureau and Merti Woreda Health Bureau. Written informed consent was obtained from each study participants after the purpose of the study was explained to them. The study was conducted in accordance with the Declaration of Helsinki.

Results

Sociodemographic and obstetric characteristics

Out of 364 pregnant women who participated in the current study, 121 (33.2%) had no formal education, 354 (97.3%) were married, and 160 (44%) were in the second trimester. The age of the study participants ranged from 16 to 40 years with a mean age of 28 years (Table 1).

Table 1. Sociodemographic and obstetric characteristics of the study participants, Merti district, Southeastern Oromia, March to September 2018 (N = 364).

Variables Frequency n (%)
Age group in years 18–24 132 (36.3)
25–34 165 (45.3)
≥35 67 (18.4)
Education level No formal education 121 (33.2)
Primary education 177 (48.6)
Above primary education 66 (18.1)
Marital status Married 354 (97.3)
Single 6 (1.7)
Divorced 4 (1.1)
Occupation Farmer 152 (41.8)
Government employee 9 (2.5)
Housewives 203 (55.8)
Gestation First trimester 63 (17.3)
Second trimester 160 (44.0)
Third trimester 141 (38.7
Gravidity Primigravidae 117 (32.1)
Secondigravidae 145 (39.8)
Multigravidae 102 (28.1
ANC Attendance Yes 266 (73.0)
No 98 (27.0)
Place of residence Urban 103 (28.3)
Rural 261 (71.7)

ANC: Antenatal care.

Prevalence of API

The prevalence of API among pregnant women in the current study was 13(3.6%) 95% CI: [2.1, 6.01]. The proportion of P. falciparum and P.vivax was 6(46.2%) and 7(53.8%) respectively. Identical results were obtained by both RDT and microscope. Of the microscopically confirmed cases, 4(30.8%) had a gametocyte stage. The proportion of the gametocyte stage of P. falciparum was 3(50%), whereas the proportion of P. vivax gametocyte was 1(14.3%). The geometric mean density of the asexual stage of the parasites was 994.7(interquartile [IQR], 320 to 2200) parasites/ul. The geometric mean gametocyte density was 303.3 (interquartile range [IQR], 160 to 600). The majority of the study participants had mild parasitemia 11(84.6%), while 2(15.4%) had moderate parasitemia.

Factors associated with API

Pregnant women who did not use insecticide-treated bed net (ITN), who had a previous history of Plasmodium infection, and who lived close to stagnant water (less than 1 km from vector breeding sites) were significantly associated with API (Table 2).

Table 2. Predictors of asymptomatic Plasmodium infection among pregnant women in Merti district, March-September 2018 (N = 364).

Variables Plasmodium infection n (%) COR (95% CI) p-value AOR (95% CI)a p-value
Yes No
Age in year 18–24 5 (3.8) 127 (96.2) 2.59(0.29–22.77) 0.388 4.05(0.38–42.58) 0.243
25–34 7 (4.2) 158 (95.8) 2.92(0.35–24.32) 0.224 5.44(0.57–51.81) 0.140
>35 1 (1.5) 66 (98.5) 1 1
Residence Rural 8 (3.1) 253 (96.9) 1.50(0.48–4.68) 0.183 1.52(0.38–5.88) 0.562
Urban 5 (4.8) 98 (95.2) 1 1
Gestational Age of pregnancy 1st trimester 3 (4.8) 60(95.2) 3.47(0.56–21.33) 0.179 2.95(0.41–21.33) 0.284
2nd trimester 8 (5)) 152 (95) 3.65 (0.76–17.5) 0.105 3.69(0.67–20.22) 0.132
3rd trimester 2 (1.4) 139(98.6) 1 1
Previous infection by Plasmodium Yes 11 (15.5) 60 (84.5) 5.43(1.18–24.8) 0.029 5.42(1.19–29.03) 0.047
No 2 (0.7) 291 (99.4) 1 1
Living close to stagnant water Yes 10 (8.3) 111 (91.7) 6.41(1.73–23.7) 0.005 4.18(1.12–17.36) 0.049
No 3 (1.2) 240 (98.8) 1 1
ITN Yes 2 (0.67) 298 (99.3) 1 1
No 11 (17.2) 53 (82.8) 5.1(1.16–23.37) 0.036 6.52(1.17–36.44) 0.032
IRS Yes 5 (2) 249 (98) 1 1
No 8 (7.2) 102 (92.7) 1.52(0.48–4.73) 0.170 1. 75(0.44–6.57) 0.429

Gravidity of pregnancy
Primigravidae 4 (3.4) 113 (96.6) 1.16(0.25–5.43) 0.482 1.61(0.25–10.26) 0.312
Secondigravidae 6 (4.1) 139(95.9) 1.42(0.34–5.83) 0.250 3.15(0.53–18.44) 0.203
Multigravidae 3 (2.9) 99 (97.1) 1 1

ANC attendance
Yes 5 (1.8) 261 (98.1) 1 1
No 8 (8.2) 90 (91.8) 4.61(1.14–15.57) 0.231 4.06(0.98–16.74) 0.252

COR: Crude odds ratio, CI: Confidence interval, AOR: Adjusted odds ratio, IRS: Indoor residual spray, ANC: Antenatal care:, ITN: Insecticide treated bed net.

a variable with p-value <0.25 was considered for multivariable logistic regression.

The association between API and anemia

The overall proportion of anemia among pregnant women in this study was 102(28%). There was a statistically significant association between API and anemia (x2 = 27.62, p = <0.001). The proportion of anemia among Plasmodium-infected and non-infected pregnant women was 12(92.3%) and 90(25.6%), respectively (Table 3). The majority of pregnant women with mild parasitemia 10(90.9%) were anemic. All pregnant women with moderate parasitemia were anemic.

Table 3. Association between asymptomatic Plasmodium infection and anemia among study participants.

Malaria status Anemia Chi-square p -value
Anemic Normal
Positive 12 (92.3) 1 (7.7) 27.62 0
Negative 90 (25.6) 261 (74.4)
Total 102 (28.0) 262 (72.0)    

Discussion

In the current study, the overall prevalence of API among pregnant women was 3.6%. This finding is lower compared to the results of similar studies conducted in South Ethiopia (9.1%) [17], Republic of Congo (7%) [22], Nigeria (22–38.8%) [23, 24], and Congo (10.8%) [25]. A systematic review and meta-analysis conducted in Ethiopia also estimated the high prevalence of asymptomatic malaria (7.83) [26]. The low prevalence of API among pregnant women in this study could be due to increased malaria control interventions in Ethiopia [27] or difference in malaria epidemiology between the study areas. The present study was conducted during a minor malaria transmission season which could also contribute to the lower prevalence of API among pregnant women reported in this study. On the other hand, the prevalence of API documented in this study is similar to the findings of a study conducted in Bangladesh, which reported a 2.3% prevalence of malaria among pregnant women [28]. The fact that we did not use molecular techniques which can detect submicroscopic Plasmodium infection could have been underestimated the prevalence of API. A study conducted in Colombia reported a high prevalence of submicroscopic Plasmodium infection (79%) by using a quantitative polymerase chain reaction [29].

There is growing evidence that shows the high transmission of P. vivax in Africa [3]. In the present study, the prevalence of P. vivax was slightly higher (53.8%) than P. falciparum (46.2%) which is in contrast to the national Plasmodium species composition which shows a higher proportion of P. falciparum than P. vivax [30]. Recent studies conducted in different parts of Ethiopia have also indicated a similar shift in Plasmodium species composition from P. falciparum predominance to P. vivax predominance [17, 31, 32]. This could be explained by the fact that the prevention and control activities of malaria in Ethiopia mainly focus on P. falciparum [33]. Treatment and diagnostic policies aimed exclusively on P. falciparum are far less efficient in controlling endemic P. vivax [3]. Other possible reasons may be climate variability or P.vivax might have developed resistance to chloroquine [34].

Malaria transmission largely depends on the presence of viable gametocytes in peripheral blood circulation, which are picked up by Anopheles mosquitoes during a blood meal [35, 36]. Gametocyte carriers are reservoirs of infection that play a key role in sustaining malaria transmission in the community [37]. In this study, the gametocyte carriage rate among pregnant women was 30.8%. The transmission of Plasmodium species from humans to mosquitoes requires the presence of gametocytes in the human peripheral blood. Thus, the detection of asymptomatic cases with circulating gametocytes signals their importance in maintaining sustained transmission in the study area. Indeed, the presence of asymptomatic cases is a big challenge for the management of elimination programs in the malaria-endemic area.

In the present study, ITN use, previous history of Plasmodium infection, and living close to vector breeding sites were the main predictors of API in the study area. Pregnant women who did not use ITN were 6.5 times more likely to have API as compared to those who used ITN. This finding is comparable with reports from the Southern part of Ethiopia [17] and Nigeria [24]. Educating pregnant women on the role of ITNs in preventing malaria will impact positively in reducing the prevalence of malaria. In the present study, we observed some individuals who used ITNs for a different purpose, for instance for the temporary storage of maize rather than using at night for mosquito control.

Pregnant women who lived close to the vector-breeding sites were 4 times more likely to have API as compared to those who lived away from the vector-breeding site. This is in agreement with studies conducted in West Arsi Zone [32] and the Southwestern part of Ethiopia [38]. There was also a statistically significant association between API and previous infection by Plasmodium. Individuals who had a previous history of Plasmodium infections were 5 times more like to have API compared to those with no previous history of malaria. These results underscore the need to further evaluate ways to optimize the management of API in pregnant women living in malaria-endemic areas. Even though gravidity was not significantly associated with API (p>0.05) there was a high proportion of API among pregnant women with two gravidities. In endemic areas, overtime pregnant women develop antibodies to Plasmodium variant surface antigen. This could protect pregnant women in subsequent pregnancies from Plasmodium infection [39].

Asymptomatic Plasmodium infection is one of the major causes of anemia in malaria-endemic settings. Our study also suggested that Plasmodium infections in pregnant women contribute to maternal anemia. Other studies in Ethiopia [17] and elsewhere [4043] have also reported a significant association between API and anemia among pregnant women. The proportion of anemia among pregnant women in the current study (28.0%) is low compared to the findings reported from Nigeria (38.85%) [23]; however, it is high compared to report from India (23%) [44]. It might be difficult to attribute the proportion of anemia solely to API as other causes such as helminthiasis [45], malnutrition, HIV infection [46], and sickle cell anemia could be responsible for it.

Conclusion

Asymptomatic Plasmodium infection and anemia during pregnancy is common the study area. Factors such as previous history of malaria, living close to stagnant water, and lack of ITN use were the main predictors of API among pregnant women. Appropriate treatment and control of API in the study area are required.

Supporting information

S1 File. Questionnaire.

(PDF)

S2 File. Raw data in SPSS.

(SAV)

Acknowledgments

We would like to thank the study area zone administrative, the Village leaders, and the health extension workers for their support during the study. We would also like to thank the study participants for their cooperation in providing the information and blood sample necessary for this study.

Abbreviations

API

Asymptomatic Plasmodium infection

ITN

Insecticide treated bed net

WHO

World Health Organization

RDT

Rapid diagnostic test

WBC

White blood cell

IRS

Indoor residual spray

ANC

Antenatal care

Data Availability

All data are available in the manuscript.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Gething PW, Casey DC, Weiss DJ, Bisanzio D, Bhatt S, Cameron E, et al. Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015. New England Journal of Medicine. 2016; 375(25):2435–45. 10.1056/NEJMoa1606701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.WHO. World malaria report 2019. Geneva: World Health Organization, 2019. [Google Scholar]
  • 3.Twohig KA, Pfeffer DA, Baird JK, Price RN, Zimmerman PA, Hay SI, et al. Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS neglected tropical diseases. 2019; 31:13(1):e0007140. 10.1371/journal.pntd.0007140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sinka ME, Bangs MJ, Manguin S, Rubio-Palis Y, Chareonviriyaphap T, Coetzee M, et al. A global map of dominant malaria vectors. Parasites & vectors. 2012; 5(1):1–1. 10.1186/1756-3305-5-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sinka ME, Bangs MJ, Manguin S, Coetzee M, Mbogo CM, Hemingway J, et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic précis. Parasites & vectors. 2010; 3(1):1–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gajida AU, Iliyasu Z, Zoakah AI. Malaria among antenatal clients attending primary health care facilities in Kano state, Nigeria. Annals of African medicine. 2010;9(3). 10.4103/1596-3519.68352 [DOI] [PubMed] [Google Scholar]
  • 7.Dellicour S, Tatem AJ, Guerra CA, Snow RW, Ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010; 26;7(1):e1000221. 10.1371/journal.pmed.1000221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Broadhead RL. Malaria in pregnancy and its consequences for the infant in rural Malawi. Annals of Tropical Medicine & Parasitology. 1999; 1:93(sup1):S25–33. [DOI] [PubMed] [Google Scholar]
  • 9.Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, Carlton JM, et al. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malaria journal. 2012; 11(1):1–5. 10.1186/1475-2875-11-29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert review of anti-infective therapy. 2013; 1:11(6):623–39. 10.1586/eri.13.45 [DOI] [PubMed] [Google Scholar]
  • 11.Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nature Reviews Microbiology. 2014; 12(12):833–40. 10.1038/nrmicro3364 [DOI] [PubMed] [Google Scholar]
  • 12.Mohanna B, Bin Ghouth AS, Raja’a YA. Malaria signs and infection rate among asymptomatic schoolchildren in Hajr Valley, Yemen. EMHJ-Eastern Mediterranean Health Journal. 2007; 13 (1):35–40. [PubMed] [Google Scholar]
  • 13.Nzobo BJ, Ngasala BE, Kihamia CM. Prevalence of asymptomatic malaria infection and use of different malaria control measures among primary school children in Morogoro Municipality, Tanzania. Malaria journal. 2015; 14(1):1–7. 10.1186/s12936-015-1009-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.de Mast Q, Syafruddin D, Keijmel S, Riekerink TO, Deky O, Asih PB, et al. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. haematologica. 2010; 95(7):1068. 10.3324/haematol.2009.019331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Desai M, Ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. The Lancet infectious diseases. 2007; 17(2):93–104. 10.1016/S1473-3099(07)70021-X [DOI] [PubMed] [Google Scholar]
  • 16.Nega D, Dana D, Tefera T, Eshetu T. Prevalence and predictors of asymptomatic malaria parasitemia among pregnant women in the rural surroundings of Arbaminch Town, South Ethiopia. PLoS One. 2015; 10(4):e0123630. 10.1371/journal.pone.0123630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.CSA. The population and Housing Census of Ethiopia Results at Country Level: Office of Population and Housing Census commission Central Statistical Authority, Addis Ababa, 2016. [Google Scholar]
  • 18.McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, et al. White blood cell counts and malaria. The Journal of infectious diseases. 2005; 192(2):323–30. 10.1086/431152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Offei BE. Factors Associated with Malaria in Pregnancy among Women Attending Antenatal Clinic at Dodowa District Hospital in the Greater Accra Region (Doctoral dissertation, University of Ghana).
  • 20.Akiyama T, Pongvongsa T, Phrommala S, Taniguchi T, Inamine Y, Takeuchi R, et al. Asymptomatic malaria, growth status, and anaemia among children in Lao People’s Democratic Republic: a cross-sectional study. Malaria journal. 2016; 15(1):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yalew A, Terefe B, Alem M, Enawgaw B. Hematological reference intervals determination in adults at Gondar university hospital, Northwest Ethiopia. BMC research notes. 2016; 9(1):1–9. 10.1186/s13104-016-2288-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Carmona-Fonseca J, Arango EM. Asymptomatic plasmodial infection in pregnant women: a global scenario. Journal of vector borne diseases. 2017; 54(3):201. 10.4103/0972-9062.217610 [DOI] [PubMed] [Google Scholar]
  • 23.Ogbu GI, Aimakhu CO, Anzaku SA, Ngwan S, Ogbu DA. Prevalence of malaria parasitaemia among asymptomatic women at booking visit in a tertiary hospital, North-central Nigeria. Circulation. 2015; 2(29):34–6. [Google Scholar]
  • 24.Emiasegen SE, Giwa FJ, Ajumobi O, Ajayi IO, Ahmed SA, Olayinka AT. Asymptomatic Plasmodium falciparum parasitaemia among pregnant women: a health facility-based survey in Nassarawa-Eggon, Nigeria. Malaria World J. 2017; 15(24):25–34. [PMC free article] [PubMed] [Google Scholar]
  • 25.Francine N, Damien B, Anna F, Michael K, Christevy VJ, Felix KK. Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the Republic of Congo. Acta tropica. 2016; 153:111–5. 10.1016/j.actatropica.2015.10.009 [DOI] [PubMed] [Google Scholar]
  • 26.Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, et al. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malaria journal. 2009; 8(1):1–8. 10.1186/1475-2875-8-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tegegne Y, Asmelash D, Ambachew S, Eshetie S, Addisu A, Jejaw Zeleke A. The prevalence of malaria among pregnant women in Ethiopia: a systematic review and meta-analysis. Journal of parasitology research. Volume 2019, Article ID 8396091, 9 pages 10.1155/2019/8396091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Khan WA, Galagan SR, Prue CS, Khyang J, Ahmed S, Ram M, et al. Asymptomatic Plasmodium falciparum malaria in pregnant women in the Chittagong Hill Districts of Bangladesh. PLoS One. 2014; 9(5):e98442. 10.1371/journal.pone.0098442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.FMoH. Ethiopia National Malaria Indicator Survey. Federal Ministry of Health of Ethiopia, 2016 [Google Scholar]
  • 30.Arango EM, Samuel R, Agudelo OM, Carmona-Fonseca J, Maestre A, Yanow SK. Molecular detection of malaria at delivery reveals a high frequency of submicroscopic infections and associated placental damage in pregnant women from northwest Colombia. The American journal of tropical medicine and hygiene. 2013; 89(1):178–83. 10.4269/ajtmh.12-0669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Woyessa A, Deressa W, Ali A, Lindtjørn B. Evaluation of CareStart™ malaria Pf/Pv combo test for Plasmodium falciparum and Plasmodium vivax malaria diagnosis in Butajira area, south-central Ethiopia. Malaria journal. 2013; 12(1):1–1. 10.1186/1475-2875-12-218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Golassa L, Baliraine FN, Enweji N, Erko B, Swedberg G, Aseffa A. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia. BMC infectious diseases. 2015; 15(1):1–0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chala B, Petros B. Malaria in Finchaa sugar factory area in western Ethiopia: assessment of malaria as public health problem in Finchaa sugar factory based on clinical records and parasitological surveys, western Ethiopia. Journal of Parasitology and Vector Biology. 2011; 3(4):52–8. [Google Scholar]
  • 34.Mekonnen SK, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malaria journal. 2014; 13(1):1–9. 10.1186/1475-2875-13-244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, Ter Kuile F, et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. The American journal of tropical medicine and hygiene. 1999; 60(6):1019–23. 10.4269/ajtmh.1999.60.1019 [DOI] [PubMed] [Google Scholar]
  • 36.Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, et al. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malaria journal. 2004; 3(1):1–6. 10.1186/1475-2875-3-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Suárez-Mutis MC, Cuervo P, Leoratti F, Moraes-Avila SL, Ferreira AW, Fernandes O, et al. Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil. Revista do Instituto de Medicina Tropical de São Paulo. 2007; 49(3):159–64. 10.1590/s0036-46652007000300005 [DOI] [PubMed] [Google Scholar]
  • 38.Degefa T, Zeynudin A, Zemene E. High prevalence of gametocyte carriage among individuals with asymptomatic malaria: implications for sustaining malaria control and elimination efforts in Ethiopia. Human Parasitic Diseases. 2016; (8):17–25. [Google Scholar]
  • 39.Nega D, Dana D, Tefera T, Eshetu T. Anemia associated with asymptomatic malaria among pregnant women in the rural surroundings of Arba Minch Town, South Ethiopia. BMC research notes. 2015; 8(1):1–6. 10.1186/s13104-015-1081-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Cutts JC, Agius PA, Lin Z, Powell R, Moore K, Draper B, et al. Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review. BMC medicine. 2020; 18(1):1–21. 10.1186/s12916-019-1443-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Matangila JR, Lufuluabo J, Ibalanky AL, da Luz RA, Lutumba P, Van Geertruyden JP. Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo. Malaria journal. 2014; 13(1):1–0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Corrêa G, Das M, Kovelamudi R, Jaladi N, Pignon C, Vysyaraju K, et al. High burden of malaria and anemia among tribal pregnant women in a chronic conflict corridor in India. Conflict and health. 2017; 11(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Adam I, Khamis AH, Elbashir MI. Prevalence and risk factors for anaemia in pregnant women of eastern Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005; 99(10):739–43. 10.1016/j.trstmh.2005.02.008 [DOI] [PubMed] [Google Scholar]
  • 44.Sohail M, Shakeel S, Kumari S, Bharti A, Zahid F, Anwar S, et al. Prevalence of malaria infection and risk factors associated with anaemia among pregnant women in semiurban community of Hazaribag, Jharkhand, India. BioMed research international. 2015; 13:2015. 10.1155/2015/740512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Larocque R, Casapia M, Gotuzzo E, Gyorkos TW. Relationship between intensity of soil-transmitted helminth infections and anemia during pregnancy. The American journal of tropical medicine and hygiene. 2005; 73(4):783–9. [PubMed] [Google Scholar]
  • 46.Antelman G, Msamanga GI, Spiegelman D, Urassa EJ, Narh R, Hunter DJ, et al. Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania. The Journal of nutrition. 2000; 130(8):1950–7. 10.1093/jn/130.8.1950 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Questionnaire.

(PDF)

S2 File. Raw data in SPSS.

(SAV)

Data Availability Statement

All data are available in the manuscript.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES